China HealthのEBITDA margin
China HealthのEBITDA marginは何ですか。
China Health Group Inc.のEBITDA marginは135.28%です。
EBITDA marginの定義は何ですか。
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
HKSEのセクタHealth CareにおけるEBITDA marginの企業と比べるChina Health
China Healthは何をしますか。
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
China Healthと類似のebitda margin
- VardhmanのEBITDA marginは132.44%です。
- Flow CapitalのEBITDA marginは132.98%です。
- BlackRock Muni Quality Fund II IncのEBITDA marginは133.65%です。
- Chesapeake Granite Wash TrustのEBITDA marginは134.38%です。
- Rand CapitalのEBITDA marginは134.64%です。
- Apollo Tactical Income Fund IncのEBITDA marginは134.87%です。
- China HealthのEBITDA marginは135.28%です。
- Clough Global Dividend and Income FundのEBITDA marginは135.50%です。
- Calamos Global Dynamic Income FundのEBITDA marginは136.23%です。
- Atul LtdのEBITDA marginは136.25%です。
- Midwich PlcのEBITDA marginは137.18%です。
- BlackRock Munienhanced Fund IncのEBITDA marginは137.19%です。
- Africa OilのEBITDA marginは137.63%です。